Example: Heart Attack

Clinical Trials Sponsored by Memory Pharmaceuticals

Total 5 results

    • NCT00725855
      Unknown status
      A Single-Center, Double-Blind (DB) Study of MEM 3454 on P50 Sensory Gating and Mismatch Negativity in Schizophrenia Patients
      Conditions: Schizophrenia
    • NCT00604760
      Unknown status
      Study to Evaluate the Safety and Efficacy of MEM 3454 as Adjunctive Treatment in Combination With a Preexisting Antipsychotic in Patients With Cognitive Impairment Associated With Schizophrenia
      Conditions: Cognitive Impairment Associated With Schizophrenia
    • NCT00454870
      Completed
      Safety and Efficacy of MEM 3454 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease
      Conditions: Alzheimer's Disease
    • NCT00374920
      Completed
      Safety and Efficacy of MEM 1003 Versus Placebo for the Treatment of Patients With Bipolar I Disorder
      Conditions: Bipolar Disorder With Manic or Mixed Episodes
    • NCT00257673
      Completed
      Safety and Efficacy of MEM 1003 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease
      Conditions: Alzheimer's Disease
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations